J Biol Chem, Vol. 274, Issue 37, 26296-26304, September 10, 1999
Stereoselective Carveol Dehydrogenase from Rhodococcus
erythropolis DCL14
A NOVEL NICOTINOPROTEIN BELONGING TO THE SHORT CHAIN
DEHYDROGENASE/REDUCTASE SUPERFAMILY*
Mariët J.
van der Werf
§,
Cornelly
van der Ven
,
Fabien
Barbirato
,
Michel H. M.
Eppink¶,
Jan A. M.
de
Bont
, and
Willem J. H.
van Berkel¶
From the
Division of Industrial Microbiology,
Department of Food Technology and Nutritional Sciences, Wageningen
University, Bomenweg 2, 6703 HD Wageningen, The Netherlands and the
¶ Laboratory of Biochemistry, Department of Biomolecular Sciences,
Wageningen University, Dreijenlaan 3, 6703 HA Wageningen, The Netherlands
 |
ABSTRACT |
A novel nicotinoprotein, catalyzing the
dichlorophenolindophenol-dependent oxidation of carveol to
carvone, was purified to homogeneity from Rhodococcus
erythropolis DCL14. The enzyme is specifically induced after
growth on limonene and carveol.
Dichlorophenolindophenol-dependent carveol dehydrogenase (CDH)
is a homotetramer of 120 kDa with each subunit containing a tightly
bound NAD(H) molecule. The enzyme is optimally active at pH 5.5 and
50 °C and displays a broad substrate specificity with a preference
for substituted cyclohexanols. When incubated with a diastereomeric
mixture of (4R)- or (4S)-carveol, CDH
stereoselectively catalyzes the conversion of the
(6S)-carveol stereoisomers only. Kinetic studies with pure
stereoisomers showed that this is due to large differences in
Vmax/Km values and
simultaneous product inhibition by (R)- or
(S)-carvone. The R. erythropolis CDH gene
(limC) was identified in an operon encoding the enzymes
involved in limonene degradation. The CDH nucleotide sequence revealed
an open reading frame of 831 base pairs encoding a 277-amino acid
protein with a deduced mass of 29,531 Da. The CDH primary structure
shares 10-30% sequence identity with members of the short chain
dehydrogenase/reductase superfamily. Structure homology modeling with
trihydroxynaphthalene reductase from Magnaporthe grisea
suggests that CDH from R. erythropolis DCL14 is an
/
one-domain protein with an extra loop insertion involved in NAD binding
and a flexible C-terminal part involved in monoterpene binding.
 |
INTRODUCTION |
Terpenes are the largest class of secondary plant metabolites (1).
They are generally regarded as derivatives of isoprene and are
classified based on the number of isoprene units linked. Monoterpenes
are branched chain C-10 hydrocarbons formed from two isoprene units.
They are widely distributed in nature, and over 400 different naturally
occurring monoterpenes have been identified (2). Volatile monoterpene
emission from trees is estimated at 127 × 1014 g
carbon/year (3).
Limonene (4-isopropenyl-1-methylcyclohexene), a monocyclic monoterpene,
is the most widespread terpene in the world and is formed by over 300 plants (4). (4R)-(+)-Limonene is the most widespread form.
(4R)-Limonene is the major constituent of citrus peel
essential oils, where it is usually found in concentrations between 90 and 96% (5). However, several plants form a mixture of both
enantiomers of limonene, whereas others produce only the (4S)-enantiomer (4).
Several pathways for the microbial degradation of limonene have been
postulated so far (6-10), but most of these pathways have not been
substantiated by biochemical studies. The best studied microbial
degradation pathway for limonene involves the hydroxylation at the
C7-methyl group resulting in the formation of perillyl alcohol (6, 7). Two enzymes of this pathway, perillyl alcohol dehydrogenase and perillyl aldehyde dehydrogenase, have been partially purified (11, 12). Also an enzyme from one of the other limonene transformation pathways,
-terpineol dehydratase, was partially purified from two different Pseudomonas species (8, 13).
We recently isolated Rhodococcus erythropolis DCL14, a
strain able to grow on limonene as sole carbon and energy source that contains a novel degradation pathway for limonene (14). Cells grown on
limonene and carveol were found to contain a
DCPIP1-dependent carveol
dehydrogenase (CDH) that converts carveol into carvone (Fig.
1). We here report on the purification,
characterization, gene cloning, sequence determination, and structure
homology modeling of this novel enzyme.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Reaction catalyzed by
DCPIP-dependent CDH from R. erythropolis DCL 14. Numbers in carveol refer to the carbon
atom numbering.
|
|
 |
EXPERIMENTAL PROCEDURES |
Organism and Culture Conditions
R. erythropolis DCL14 was isolated with
(4R)-dihydrocarveol as the carbon and energy source as
described previously (15). The strain was subcultured every month and
grown at 30 °C on a yeast extract-glucose agar plates for 2 days,
after which the plates were stored at room temperature. Cultures were
grown in 5-liter Erlenmeyer flasks containing 1 liter of mineral salts medium (16) with 0.01% (v/v) carbon source and fitted with rubber stoppers. The flasks were incubated at 30 °C on a horizontal shaker oscillating at 1 Hz with an amplitude of 10 cm. After growth was observed, the concentration of the toxic substrates was increased with
daily steps of 0.01% (v/v) until a total of 0.1% (v/v) carbon source
had been added.
Cells for enzyme purification were grown fed-batch on limonene in a
fermentor as described previously (15). Cells were collected by
centrifugation (4 °C, 10 min at 16,000 × g) and
washed with 50 mM potassium phosphate buffer, pH 7.0. The
pellet was resuspended in 7 ml of this buffer containing 0.1% Tween 80 and stored at
20 °C.
Chemicals
(4R)-Carveol (mixture of two diastereomers),
(
)-(R)- and (+)-(S)-carvone were from Acros and
DCPIP was from Merck. SDS was purchased from BDH. NAD+
(100%), NADP+ (98%), NADH (98%), and NADPH (98%) were
obtained from Roche Molecular Biochemicals. DEAE-Sepharose CL-6B, Octyl
Sepharose, Sephacryl S300, Superdex 200 HR 10/30, and Resource-Q were
obtained from Amersham Pharmacia Biotech. Hydroxyapatite and Bio-Gel
P6DG were from Bio-Rad. (4S)-Carveol (mixture of two
diastereomers) was prepared by reducing (S)-carvone with
lithium aluminum hydride. (+)-(4S,
6S)-cis- (97.8%), (+)-(4S,
6R)-trans- (94.6%), (
)-(4R, 6R)-cis- (96.8%), and (
)-(4R,
6S)-trans-carveol (99.2%) were obtained after
preparative GC separation. 30 µl of a 10% (4R)- or
(4S)-carveol solution in acetone was injected on a packed
column (2.0 m × 4 mm) filled with 8.6 g of Chromsorb 100-120
containing 9.8% Carbowax. GC was performed on a Varian model 3700 GC
equipped with an thermo conductor detector. The detector and filament
temperatures were 230 and 260 °C, respectively. The injector and
oven temperatures were 200 and 120 °C, respectively, and the flow of
the carrier gas (H2) was 30 ml/min. The stereoisomers were
identified by their MS spectra and by comparing the retention times
after chiral and nonchiral GC with that of standards: (4S,
6S)-carveol; tR = 13.66 min (
-DEX
120, 120 °C), tR = 8.04 min (HP-5MS,
temperature program), MS: m/z 152 [M+] (1), 137 (10), 134 (49), 123 (11), 119 (29), 109 (65), 91 (30), 84 (100), 69 (46), 55 (58), 41 (62). (4S,
6R)-carveol; tR = 12.43 min (
-DEX
120, 120 °C), tR = 7.79 min (HP-5MS,
temperature program), MS: m/z 152 [M+] (6), 137 (10), 134 (2), 123 (7), 119 (13), 109 (100), 91 (25), 84 (59), 69 (28), 55 (36), 41 (45). (4R,
6R)-carveol; tR = 13.45 min (
-DEX
120, 120 °C), tR = 8.04 min (HP-5MS,
temperature program), MS spectrum: same as that of (4S,
6S)-carveol. (4R, 6S)-carveol;
tR = 12.29 min (
-DEX 120, 120 °C),
tR = 8.04 min (HP-5MS, temperature program), MS spectrum: same as that of (4S, 6R)-carveol. All other
chemicals were of the highest purity commercially available.
Preparation of Cell Extract
Aliquots of the frozen cell suspension (7 ml) were thawed and
disrupted by sonication (20 min, 30% duty cycle, output control 2.3)
with a Branson sonifier 250. Cell debris was removed by centrifugation at 20,000 × g for 20 min (4 °C). The supernatant
was used as the cell extract.
Carveol Dehydrogenase Assay
NAD(P)+-dependent CDH activity was
determined spectrophotometrically by monitoring the formation of
NAD(P)H at 340 nm (
340 = 6.22 mM
1 cm
1). Activity was measured
at 30 °C in an incubation (1 ml) containing 100 µl of cell
extract, 50 mM Tris/HCl buffer, pH 9.0, 1 mM
NAD(P)+, and 1 mM carveol. The reaction was
started by the addition of substrate. Specific activities were
calculated from the linear part of the reaction and were corrected for
endogenous activity. DCPIP-dependent CDH activity was
determined spectrophotometrically by monitoring the decrease in
absorbance at 600 nm due to the reduction of DCPIP. Activity was
measured at 30 °C in an incubation (1 ml) containing 25 µl of
enzyme solution, 50 mM citrate buffer, pH 6.0, 0.075 mM DCPIP, and 1 mM carveol. The molar
absorption coefficient for DCPIP at 600 nm and pH 6.0 was
600 = 16.9 mM
1
cm
1. One unit of CDH activity was defined as the amount
of enzyme that converted 1 µmol of DCPIP/min under assay conditions.
For the determination of the pH optimum of enzyme catalysis, the pH dependence of the molar absorption coefficient of DCPIP was corrected for (17). Steady state kinetic parameters were determined from incubations (1 ml; 30.0 °C) containing 6.7 µg of CDH, 50 mM citrate buffer, pH 5.5, 0.10 mM DCPIP, and
substrate at concentrations ranging between 0.015 and 3.5 mM enantiopure carveol. For the determination of product
inhibition constants (Ki), 0.2 mM
enantiopure carvone was added to the assay. The molar absorption coefficient for DCPIP at 600 nm and pH 5.5 was
600 = 12.9 mM
1 cm
1. Apparent
Km, Ki, and
Vmax values were calculated from Lineweaver-Burk
plots as described previously (18). The substrate specificity of CDH
was determined by replacing carveol in the standard activity assay with
1 mM of the other substrates. DCPIP was reduced chemically
by adding an equimolar amount of ascorbate (17).
The stereoselectivity of CDH was determined by monitoring carveol
conversion by chiral GC. Different vials (15 ml) containing the
reaction mixture were started at the same time. The reaction mixtures
(2 ml) consisted of CDH, 50 mM citrate buffer, pH 6.0, 3 mM DCPIP, and 2 mM carveol. The vials were
fitted with Teflon Mininert valves (Supelco Inc.) preventing the
evaporation of carveol. The vials were placed in a shaking water bath
(30 °C), and periodically a vial was removed from the water bath,
and the reaction was terminated by the addition of 1 ml of ethyl
acetate. The vials were vigorously shaken to accomplish quantitative
extraction of the terpenes. The ethyl acetate layer was pipetted in a
microcentrifuge tube and centrifuged (3 min, 13.000 rpm) to achieve
optimal separation of the two layers. Subsequently 1 µl of the ethyl
acetate layer was analyzed by GC.
Enzyme Purification
All purification steps were performed at 4 °C. Buffers
contained 10% glycerol and 0.1% Tween 80, and the pH was 7.0. If
necessary, pooled fractions were concentrated by ultrafiltration with
an Amicon ultrafiltration unit using a YM-10 membrane.
Hydrophobic Interaction Chromatography--
Cell extract (15 ml)
was applied onto an Octyl Sepharose column (2.5 × 31 cm)
equilibrated with 25 mM potassium phosphate buffer
containing 1 M NaCl and eluted with the same buffer (flow rate, 0.75 ml/min; collected fraction volume, 7.5 ml). Fractions containing DCPIP-dependent CDH activity were pooled and
adjusted to 80% ammonium sulfate saturation. After 15 min at 0 °C,
the precipitate was collected by centrifugation (15 min at 27,000 × g). The pellet was resuspended in 5 ml of 15 mM potassium phosphate buffer.
Gel Filtration--
The solubilized precipitate was applied onto
a Sephacryl S300 column (2.5 × 98 cm) equilibrated with 15 mM phosphate buffer and eluted with the same buffer (flow
rate, 0.75 ml/min; collected fraction volume, 7.5 ml). Fractions
containing CDH activity were pooled.
Hydroxyapatite Chromatography--
The pooled fractions from the
gel filtration step were applied to a hydroxyapatite column (5 × 6 cm) equilibrated with 15 mM potassium phosphate buffer
and eluted with the same buffer (flow rate, 0.5 ml/min; collected
fraction volume, 5 ml). The fractions containing CDH activity were pooled.
Anion Exchange Chromatography--
The pooled fractions from the
hydroxyapatite chromatography step were applied onto a DEAE Sepharose
CL-6B column (2.5 × 31 cm) equilibrated with 25 mM
potassium phosphate buffer. The column was washed with 200 ml of the
same buffer (flow rate, 0.75 ml/min; collected fraction volume, 7.5 ml), and subsequently the enzyme was eluted with a linear gradient of
0-1 M NaCl in the same buffer (total volume, 1 liter). CDH
eluted at a concentration of 300 mM NaCl. Active fractions
were pooled, concentrated by ultrafiltration, and stored at
4 °C.
Electrophoresis and Molecular Mass Determinations
The relative subunit molecular mass of CDH was determined by
SDS-polyacrylamide gel electrophoresis. A 12.5% (w/v) slab gel was
prepared by the method of Laemmli (19). The Amersham Pharmacia Biotech
low molecular mass calibration kit containing phosphorylase b (94 kDa),
bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase
(30 kDa), soybean trypsin inhibitor (20.1 kDa), and
-lactalbumin
(14.4 kDa) was used as a reference. Proteins were stained with
Coomassie Brilliant Blue G. The relative molecular mass of native CDH
was determined by gel filtration on Superdex 200. The column was
calibrated with blue dextran 2000, ferritine (440 kDa), catalase (232 kDa), aldolase (158 kDa), p-hydroxybenzoate hydroxylase (88 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), and
chymotrypsinogen A (25 kDa).
Identification of Prosthetic Group of CDH
The prosthetic group of CDH was extracted by urea unfolding,
essentially as described by Arfman et al. (20). Urea (final concentration, 6 M) was added to 1.85 mg of purified CDH in
1 ml of 25 mM Hepes/NaOH, pH 7.5, containing 1 mM dithiothreitol. After standing for 10 min at 50 °C,
the enzyme sample (1.4 ml) was eluted over a Bio-Gel P6DG column
(1 × 10 cm), equilibrated with 10 mM Tris/HCl, pH
8.0, containing 6 M urea (buffer A). Fractions of 1 ml were
collected and tested for their spectral properties. Samples (200-500
µl) of the liberated prosthetic group were further analyzed on a
Resource-Q anion exchange column (30 × 6.4 mm), equilibrated with
buffer A at a flow rate of 1 ml min
1. Samples of
urea-treated NAD, NADH, NADP, and NADPH (10 nmol of each) served as
standards. After sample application, the column was washed with 5 ml of
buffer A. Bound nucleotides were then eluted with a 0-0.9
M KCl gradient in 15 ml of buffer A.
Analytical Methods
Protein was determined by the method of Bradford (22) with
bovine serum albumin as the standard. The N-terminal amino acid sequence of purified CDH was determined by Edman degradation at the
Protein Sequencing Facility Leiden, Department of Medical Biochemistry,
Sylvius Laboratory, Leiden, The Netherlands. The metal composition of
CDH (16 µM subunit) was determined by inductively coupled
plasma-MS using a Perkin-Elmer Elan 6000.
Carveol and carvone were analyzed by chiral GC on fused silica
cyclodextrin
-DEX 120 capillary column (30 m × 0.25 mm,
0.25-µm film coating; Supelco, Zwijndrecht, the Netherlands). GC was
performed on a Chrompack CP9000 GC equipped with an FID detector using
N2 (1 ml min
1) as the carrier gas. The
detector and injector temperatures were 250 and 200 °C,
respectively, and the split ratio was 1:50. The isomers of carveol and
carvone were separated at oven temperatures of 120 and 80 °C,
respectively. The stereoisomers of carveol and carvone were assigned by
comparing the retention times after chiral and nonchiral GC, and their
MS spectra were compared with that of standards.
GC-MS analysis was carried out on a HP5970B quadrupole MS coupled to an
Hewlett Packard HP6890 GC equipped with a fused silica capillary column
(HP-5MS, 30 m × 0.25 mm; film thickness, 0.25 µm). Carrier gas
and flow was helium at 1.0 ml min
1. Injector temperature
was 220 °C; the temperature program was 70-175 °C at 7 °C
min
1. The injection volume was 1 µl (split ratio,
1:50). Electron-impact MS was obtained at 70 eV.
Absorption spectra were recorded at 25 °C on a Hewlett Packard HP
8453 diode array spectrophotometer. Fluorescence spectra were recorded
at 20 °C with a SLM-Aminco SPF500C spectrofluorimeter. Measurements
were performed in a quartz cuvette (10-mm path length) in a total
volume of 1 ml. Fluorescence emission spectra were recorded between 360 and 560 nm (bandwidth, 4 nm) with the excitation wavelength fixed at
280, 295, or 340 nm (bandwidth, 4 nm). Fluorescence excitation spectra
were scanned between 240 and 440 nm (bandwidth, 4 nm) at a fixed
emission wavelength of 450 nm (bandwidth, 4 nm). All fluorescence
spectra were corrected against the appropriate reference solution.
Cloning and Sequencing of the CDH Gene (limC)
The limA gene coding for limonene-1,2-epoxide
hydrolase, an enzyme involved in limonene degradation in R. erythropolis DCL14, was cloned using a combination of polymerase
chain reaction and colony filter hybridization (21). Using the
N-terminal amino acid sequence of the purified enzyme (15), two
degenerated primers were designed at the beginning and the end of the
50-amino acid-long stretch. These primers were used to synthesize a
homologous probe with which the complete limA gene and the
flanking regions were isolated from a cosmid library of R. erythropolis DCL14 (21). The nucleotide sequences of the flanking
regions of limA, containing the limC gene, were
determined by a combination of subcloning and primer walking. The
nucleotide sequences of double stranded inserts in pGEM-T were
determined by the DyeDeoxy Terminator Cycle Sequencing kit using
AmliTaq FC DNA polymerase (Perkin-Elmer).
Sequence Alignment
For sequence alignment studies a PSI-BLAST (23) search was
performed at the National Center for Biotechnology Information for
related sequences with known structure. A multiple sequence alignment
was performed by superimposing the structures of the selected sequences
with the program TOP (24), followed by the addition of the CDH gene to
the alignment profile with MACAW (25), and manual optimization.
Structure Homology Modeling
Model building of CDH was performed with MODELLER4 (26) using
the CHARMM forcefield (27). The stereochemical quality of the homology
model was verified by PROCHECK (28), and the protein folding was
assessed with PROFILE (29) and PROSAII (30), which evaluate the
compatibility of each residue to its environment independently. After
this initial verification, bad regions of the model were optimized with
the simulated annealing procedure (molecular dynamics) of the XPLOR
package (31), thereby fixing the other parts of the protein. A
simulated annealing calculation was performed for 1000 steps at 900 K,
with each step taking 0.5 femtosecond. Before and after molecular
dynamics the model was energy minimized with the conjugate gradient
algorithm of XPLOR (31); the minimization converged after 2000 cycles
(gradient, 0.1 kcal/mol). Again, the model was checked and verified.
NADH docking was performed with the program O (32), based on highly similar positions of NAD(P)H in SDR structures. NADH forcefield constants for energy minimization were derived from CHARMM. Finally, the model was verified after several rounds of energy minimization.
 |
RESULTS |
Induction of CDH Activities in R. erythropolis--
R.
erythropolis DCL14 is able to grow on a variety of monoterpenes.
During growth on these substrates, several CDH activities are induced
(Table I). Both NAD+- and
DCPIP-dependent CDH activities were present in cell
extracts of R. erythropolis DCL14 grown on
(4S)-carveol. Separation by anion exchange chromatography
revealed at least four different CDH activities: an
NADP+-dependent CDH, an
NAD+-dependent CDH with a high activity with
(4S)-carveol, an NAD+-dependent CDH
with a high activity with (4R)-carveol, and a
DCPIP-dependent CDH (results not shown). Only the latter
activity was markedly induced after growth on limonene and carveol
(Table I).
View this table:
[in this window]
[in a new window]
|
Table I
(4S)- and (4R)-CDH activities in cell extracts of R. erythropolis DCL14
grown on various carbon sources
Activities are in nmol min 1 mg 1.
|
|
Purification of DCPIP-dependent CDH--
During our initial
efforts to purify the inducible CDH, the enzyme appeared to be rather
unstable, especially at high ionic strength. A mixture of 0.1% (v/v)
Tween 80 and 10% (v/v) glycerol stabilized CDH. The purification
scheme for CDH is presented in Table II.
The enzyme was purified 13-fold with an overall yield of 50%. The
ratio of the activity of CDH with (4S)- and
(4R)-carveol remained constant during purification.
SDS-polyacrylamide gel electrophoresis of the purified enzyme revealed
one distinct band, corresponding to a protein with a subunit mass of
about 40 kDa (Fig. 2). Analytical gel
filtration revealed one symmetric protein peak corresponding to a
relative molecular mass of about 120 kDa. Together with the sequence
data (see below), this suggests that the native enzyme is a
homotetramer. Inductively coupled plasma MS analysis revealed no metal
ions as cofactors (<5% mol metal/mol enzyme).
View this table:
[in this window]
[in a new window]
|
Table II
Purification of DCPIP-dependent CDH from (4R)-limonene grown cells of
R. erythropolis DCL14
Activity was measured with (4S)-carveol as the substrate.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
SDS-polyacrylamide gel electrophoresis of CDH
from R. erythropolis DCL14. Lane 1, 20 µg CDH; lane 2, molecular mass markers.
|
|
Spectral Properties--
The absorption spectrum of CDH displayed
a typical maximum at 275 nm and a broad band of relatively low
intensity around 330 nm (Fig.
3A). Addition of dithionite,
carveol, or carvone did not affect the absorption spectrum. Upon
excitation at 340 nm, the holoenzyme exhibited a fluorescence emission
maximum near 440 nm (Fig. 3B), whereas upon excitation at
280 nm, the native enzyme showed fluorescence emission maxima at 340 and 440 nm (Fig. 4A). This
indicates that CDH contains protein-bound NAD(P)H.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Spectral properties of CDH from R. erythropolis DCL14. Spectra were recorded in 25 mM Hepes/NaOH, pH 7.0. A, absorption spectrum
(from right to left, 2.5 mg/ml and of the 10 and
50 times diluted enzyme solution). B, fluorescence emission
spectrum of 4 µM enzyme. Excitation was at 340 nm.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Spectral properties of CDH from R. erythropolis DCL14 in the presence of unfolding agents.
A, fluorescence emission spectrum of 4 µM
enzyme in 25 mM Hepes/NaOH, pH 7.0, after 1, 10, 30, 100, and 360 min of incubation with 0.5% SDS. The excitation wavelength was
280 nm. B, absorption spectrum of the urea-released cofactor
of CDH. The free cofactor was obtained by gel filtration of 40 nmol of
CDH over Bio-Gel P6DG in 10 mM Tris/HCl, pH 8.0, containing
1 mM dithiothreitol and 6 M urea. The
inset shows the absorption spectrum of the apoprotein,
eluting in the void volume of the column.
|
|
Identification of CDH-bound Cofactor--
The cofactor of CDH was
firmly bound as indicated by gel filtration and dialysis experiments.
Fluorescence spectral analysis revealed that the cofactor could be
conveniently released from the CDH apoprotein by treatment with 0.5%
SDS, 6 M urea, or 6 M guanidinium
hydrochloride. Unfolding of CDH in 0.5% SDS was rather slow as
indicated by the time-dependent disappearance of the
fluorescence emission maximum at 440 nm and increase of protein fluorescence at 340 nm (Fig. 4A). In contrast, unfolding in
6 M urea (or 6 M guanidinium hydrochloride) was
a rather rapid process, taking less than 10 min to complete (not shown).
The urea-released cofactor was separated from the apoprotein by gel
filtration. Spectral analysis revealed that the apoprotein fraction
exhibited an absorption maximum near 275 nm and no residual absorbance
at 330 nm (Fig. 4B, inset). In line with this, no
fluorescence emission was observed at 440 nm when the apoprotein sample
was excited at either 280 or 340 nm. The absorption spectrum of the dissociated cofactor exhibited maxima at 260 and 340 nm, characteristic of NAD(P)H (Fig. 4B). Furthermore, the rather high
A260/A340 ratio and
relatively low fluorescence emission at 440 nm suggested that the
CDH-bound cofactor is a mixture of oxidized and reduced pyridine nucleotide forms. The identity of the isolated cofactor was further established by anion-exchange chromatography, using conditions resulting in clear separation of NAD(H) and NAD(P)(H) (20). The
CDH-derived cofactor preparation showed two peaks of nearly equal
intensity at 260 nm, corresponding to the positions of NAD+
and NADH, respectively. In line with this, only the second elution peak
of the CDH-derived cofactor preparation displayed absorption at 340 nm.
From this it is concluded that CDH contains NAD(H) as the tightly bound
cofactor. Moreover, assuming a molar absorption coefficient
340 = 6.22 mM
1
cm
1, the amount of NAD(H) per CDH subunit was estimated.
Different enzyme preparations yielded values ranging from 0.55-0.98
mol NAD(H)/subunit, indicating that each CDH monomer contains one NAD(H) molecule as tightly bound cofactor.
Catalytic Properties--
Under the conditions of the standard
assay, CDH was optimally active at pH 5.5 and showed 25% of the
optimal activity at pH 4.6 and 7.0. The temperature optimum of CDH
activity was near 50 °C. At pH 5.5, the specific activity gradually
increased from 550 nmol min
1 mg
1 at 6 °C
to 2825 nmol min
1 mg
1 at 50 °C. At
temperatures above 35 °C, enzyme inactivation was observed during
the time span of the activity assay, and at 60 °C activity was no
longer detected. CDH used DCPIP as the electron acceptor. Over the pH
range 6-9, no activity was observed with 9,10-anthraquinone,
p-benzoquinone, cytochrome c,
N,N-dimethyl-p-nitrosoaniline, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, flavin adenine dinucleotide, ferricyanide, ferrisulfate, flavin adenine
mononucleotide, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride, menadione, methylene blue, NAD+,
NADP+, nitroblue tetrazolium, oxygen, phenazine
methosulfate, quinalizarin, tetramethyl-p-benzoquinone,
triphenyltetrazolium and ubiquinone. The presence of phenazine
methosulfate or NAD+ did not affect the
DCPIP-dependent CDH activity at any of the tested pH values.
Substrate Specificity and Stereochemistry--
CDH showed a broad
substrate specificity (Table III). The
best substrates were substituted cyclohexanols such as carveol,
3-methylcyclohexanol, and 3,5,5-trimethyl-2-cyclohexen-1-ol. Primary
alcohols such as ethanol and perillyl alcohol and short chain secondary
alcohols like 2-propanol and 1-buten-3-ol were no substrates for CDH
(Table III). Furthermore, no reverse reaction was detectable when CDH was assayed with (R)- or (S)-carvone or
(4R)-dihydrocarvone in the presence of reduced DCPIP or
NADH.
Because carveol exists in four stereoisomeric forms the kinetic
constants of CDH with the pure stereoisomers were determined (Table
IV). The highest
Vmax/Km and lowest
Km values were obtained for (4R,
6S)-carveol. Also a strong competitive product inhibition
was observed and a Ki of 0.11 and 0.23 mM were determined for (R)- and
(S)-carvone, respectively. Using a diastereomeric mixture of
either (4R)- or (4S)-carveol as the substrate,
the stereoselectivity of CDH was studied by chiral GC (Fig.
5). CDH converted only the
(6S)-stereoisomers of carveol.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
Stereoselectivity of the conversion of
carveol by CDH. A, conversion of
(4S)-carveol. B, conversion of
(4R)-carveol. The reaction mixture contained 50 mM citrate, pH 6.0, 3 mM DCPIP, 2 mM carveol, and CDH (0.06 mg/ml and 0.02 mg/ml in
panels A and B, respectively) (30 °C). ,
carvone; , (6S)-stereoisomer of carveol; ,
(6R)-stereoisomer of carveol.
|
|
N-terminal Sequence--
The N-terminal amino acid sequence
determination of purified CDH gave a tandem sequence (a mixture of two
identical peptide sequences, of which one lacked the first residue).
The N-terminal sequence was determined to be
Ala-Arg-Val-Glu-Gly-Gln-Val-Leu-Ile-Thr-Gly-Ala-Ala-ArgGly-Gln-Gly-Arg-Ser-His-Ala-Ile-Lys-(Lys/Leu)-(Ala/Leu)-GluGlu-Gly.
Nucleotide Sequence--
Recently, we cloned and sequenced the
limA gene coding for limonene-1,2-epoxide hydrolase from
R. erythropolis DCL14 (21). Sequencing the flanking regions
of limA suggested that limA is the first open
reading frame of an operon encoding genes involved in the limonene
degradation pathway of this
microorganism.2 The third
open reading frame of this operon, limC, encodes a protein
of 277 amino acids with a deduced molecular mass of 29.531 Da (Fig.
6). Residues 2-29 of the derived primary
structure of limC corresponded to the N-terminal sequence of
purified CDH, indicating that limC encodes CDH. A potential
ribosomal-binding site (Shine-Dalgarno sequence), GGAGGGA, preceded the
ATG translational initiation site by 2 base pairs (Fig. 6).

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 6.
Nucleotide sequence of the limC region of R. erythropolis DCL14 and the deduced
amino acid sequence of CDH. Nucleotide sequence of the 834-base
pair DNA fragment containing the limC gene. The open reading
frame starts at base 37 and terminates at base 870. The deduced amino
acid sequence is indicated below the DNA sequence.
Underlined amino acid residues are identical to those
determined by Edman degradation of the purified enzyme. A potential
ribosome binding site (marked SD) upstream of the open
reading frame is indicated.
|
|
Amino Acid Sequence Comparison--
The derived primary structure
of CDH showed up to 33% sequence identity and 52% sequence homology
with members of the SDR superfamily. The highest degree of sequence
identity with enzymes of known structure was found for
trihydroxynaphthalene reductase (Protein Data Bank code 1YBV) from
Magnaporthe grisea (30%), human 17
-hydroxysteroid
dehydrogenase (1FMC) (29%), 3
,20
-hydroxysteroid dehydrogenase
(2HSD) from Streptomyces hydrogenans (28%), and cis-biphenyl-2,3-dihydrodiol-2,3-dehydrogenase (1BDB) from Burkholderia cepacia (28%). Fig.
7 shows a sequence alignment of CDH and
SDR enzymes of known three-dimensional structure. From the alignment it
is obvious that CDH shares many structural features with the other
members of the family. Conserved regions in the primary structure of
CDH are present throughout the sequence indicating that the enzyme has
an
/
one-domain fold. Conserved features near the N terminus
include the GXXXGXG fingerprint characteristic for the
A-
B-
B dinucleotide binding fold in dehydrogenases (42, 43) and Asp37, involved in determining the coenzyme
specificity (43). Other conserved features include the
Ser156-Tyr169-Lys173 catalytic
triad with the YXXXK fingerprint, involved in substrate oxidation (44) and the NAG sequence (residues 102-104), involved in
NADH binding (35, 43).

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 7.
Multiple sequence alignment of CDH from
R. erythropolis DCL14 and short chain
dehydrogenases/reductases of known three-dimensional structure.
The deduced amino acid sequence of CDH is aligned with the amino acid
sequences of 1,3,8-trihydroxynaphthalene reductase (1YBV) from M. grisea (33), 7 -hydroxysteroid dehydrogenase (1FMC) from
Escherichia coli (34), 3 ,20 -hydroxysteroid
dehydrogenase (2HSD) from S. hydrogenans (35),
cis-biphenyl-2,3-dihydrodiol-2,3-dehydrogenase (1BDB) from
B. cepacia (36), enoyl acyl carrier protein reductase (1ENO)
from E. coli (37), human 17- -hydroxysteroid dehydrogenase
(1FDS) (38), rat liver dihydropteridine reductase (1DHR) (39), mouse
lung carbonyl reductase (1CYD) (40), and mouse sepiapterin reductase
(1SER) (41). Secondary structure elements are underlined,
and residues discussed in the text are depicted in bold
type.
|
|
Structure Homology Modeling--
A three-dimensional model of the
CDH structure was built, based on the crystal structure of 1YBV. A
ribbon diagram of the modeled CDH structure is presented in Fig.
8; the predicted fold is highly similar
to the
/
one-domain fold of the SDR family (43). The modeled
structure suggests that CDH contains at least 7 strands (
A
G)
and 7-9 helices (
B
G). Two regions in the CDH model are not
very well defined in relation to 1YBV and the other members of the SDR
family with known three-dimensional structure. The first region
includes a loop insertion between
B and
C (residues 40-50)
located near the entrance of the NADH binding site, which is new in
relation to the other SDR members (Fig. 7). The second region concerns
a loop comprising residues 204-236; in related SDR proteins this loop
contains one or two helices and participates in substrate binding (34,
36). The modeled structure also suggests that the CDH subunits interact in a similar fashion as found in other tetrameric enzymes of the SDR
family (33-36, 40). For the tetrameric contacts, probably the
E and
F interact along the Q-axis, the
G and
G along the P-axis, and
the weakest interaction occurs with the short C-terminal regions along
the R-axis.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 8.
Ribbon diagram of the modeled
three-dimensional structure of CDH from R. erythropolis DCL14. The three-dimensional structure of CDH was predicted
by structure homology model building (26). The crystal structure of
trihydroxynaphthalene reductase (1YBV) from M. grisea (33)
served as the template. The schematic ribbon diagram was generated with
MOLSCRIPT (45). The -helices are drawn in red, the
-sheets are in yellow, the flexible substrate binding
region is in blue, the extra loop insertion (residue 40-50)
is in green, and the NADH cofactor is in purple.
The secondary structural elements are annotated together with the N and
C termini.
|
|
Mode of Coenzyme Binding--
The NADH cofactor was modeled in an
extended conformation, highly similar to related SDR members. The NADH
molecule is buried in the protein and probably shielded from solvent by
the extra loop, comprising residues 40-50 (Fig. 8). The nicotinamide
ring was modeled in the syn conformation, consistent with
the proposed stereochemistry of hydride transfer in the SDR family
(35). Asp37 interacts in the model with the 2-OH ribose of
NADH (Fig. 9), and the pyrophosphate
moiety is located near the GXXXGXG sequence of
the dinucleotide binding fold. The substrate binding cavity is enclosed
on one side by the nicotinamide ring of NADH and the active site
residue Tyr169 and on the other side by the C-terminal
substrate binding loop.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 9.
Stereoview of the C backbone of the CDH model. The N and C termini and each 15th
residue is annotated in the stereopicture. The most important residues,
Asp37, Ser156, Tyr169, and
Lys173 (gray bonds) and the NADH cofactor
(black bonds) are highlighted.
|
|
 |
DISCUSSION |
This paper describes the purification and characterization of a
DCPIP-dependent CDH, which is induced when R. erythropolis DCL14 is grown on monoterpenes. During the last
decade it has become apparent that monoterpenes play an important role
in chemical ecology where they act as attractants, repellents, sex
pheromones, or alerting pheromones or are a part of defense secretion
systems against predators (46). Remarkably, little is known about the metabolism of monoterpenes. Information regarding the enzymes involved
in the monoterpene degradation pathways is especially scarce (6, 47,
48). Although CDH activity has been detected in crude extracts of
spearmint (Mentha spicata) (49) and caraway (Carum
carvi) (50), this is the first report of a CDH purified to homogeneity.
CDH from R. erythropolis DCL14 is a homotetramer, and each
30-kDa CDH subunit contains a tightly bound cofactor that is only released after treatment with unfolding agents. The cofactor was identified as NAD(H), indicating that CDH is a nicotinoprotein. Nicotinoproteins catalyze a large spread of reactions including transhydrogenation, dehydration, dismutation, epimerization, and oxidation of alcohols and aldehydes (51-57). Nicotinoprotein
dehydrogenases can be divided in two groups. The first group includes
dehydrogenases that catalyze oxidations dependent on exogenous NAD(P).
However, due to an unusually high affinity, the (reduced) cofactor
remains (partly) bound to the enzyme, even after lengthy purification procedures or repeated crystallization. Examples are
glyceraldehyde-3-phosphate dehydrogenase (58) and mammalian
acetaldehyde dehydrogenase (56). The second group includes
nicotinoprotein dehydrogenases that are, in vitro, only
active when assayed in the presence of an artificial electron acceptor
like N,N-dimethyl-4-nitrosoaniline or DCPIP (57,
59, 60). In vivo, these enzymes probably regenerate the
cofactor by delivering the reduction equivalents directly to a
component of an electron transport chain (61). Examples are methanol
dehydrogenase from Amycolatopsis methanolica (57), short
chain primary alcohol dehydrogenase from A. methanolica (60), and medium chain primary alcohol dehydrogenase from
Methanosarcina barkeri (59). Being exclusively active with
DCPIP, it is evident that CDH belongs to this second group of
nicotinoprotein dehydrogenases. However, the physiological electron
acceptor of the enzyme remains to be elucidated.
Gene cloning confirmed that CDH is involved in the biodegradation of
limonene and sequence analysis classified CDH as a member of the SDR
superfamily. These enzymes are built up by subunits of about 30 kDa, do
not contain metal cofactors, have a single
/
domain with a
A-
B-
B dinucleotide binding fold near the N termini, and
contain a highly conserved Ser-Tyr-Lys triad at their active site (44,
62). In CDH, the catalytic machinery includes Ser156,
Tyr169, and Lys173. Ser156 and
Tyr169 are likely involved in substrate activation, whereas
Lys173 presumably is involved in the orientation of the
nicotinamide ring of the cofactor (33). Moreover, the presence of an
aspartic residue, 18 residues downstream of the
GXXXGXG fingerprint, confirmed the biochemical
identification of the coenzyme specificity of CDH (40).
Structure prediction suggests that CDH contains a 10-amino acid-long
loop (residues 40-50) located near the entrance of the NADH binding
cleft. This loop, which is absent in other SDR members of known
structure, might be involved in shielding the NADH cofactor from the
bulk solvent. Another intriguing feature concerns the functional role
of the flexible loop comprising residues 204-236. As proposed for
7
-hydroxysteroid dehydrogenase (34) and confirmed by the structure
of trihydroxynaphthalene reductase complexed with tricyclazole (33),
this part of the sequence is likely involved in determining the
substrate specificity. Moreover, from the conservation of several
critical residues, we propose that in CDH a hinge bending motion of the
substrate binding loop occurs. Thr204 (N-terminal hinge)
and Asn236 (C-terminal hinge) might act as the hinges,
whereas Pro199 and Pro239 probably stabilize
the region close to the hinges (34).
CDH from R. erythropolis has a unique substrate specificity
in comparison with previously reported (secondary) alcohol
dehydrogenases (63-65). The enzyme has a preference for substituted
cyclohexanols and does not catalyze the oxidation of primary or short
chain aliphatic secondary alcohols. CDH shows an absolute
stereoselectivity with carveol, converting only the
(6S)-stereoisomers when incubated with a diastereomeric
mixture. This stereoselectivity is explained by the kinetic constants
of CDH, showing a much higher catalytic efficiency for the
(6S)-stereoisomers than for the
(6R)-stereoisomers and the simultaneous strong competitive
product inhibition. Absolute stereoselectiveness is a unique property
among secondary alcohol dehydrogenases (66-68), potentially making the
enzyme of interest for the biocatalytic production of (natural)
enantiopure compounds.
In conclusion, DCPIP-dependent CDH from R. erythropolis DCL14 is a novel nicotinoprotein with a SDR
/
one-domain fold. The enzyme catalyzes the stereoselective conversion of
monoterpenes, which further extends the functional diversity of the SDR superfamily.
 |
ACKNOWLEDGEMENTS |
We thank Martin de Wit for technical
assistance, Harro Bouwmeester (AB-DLO, Wageningen, The Netherlands) for
providing us with standards of the different stereoisomers of carveol,
Elbert van der Klift (Department of Organic Chemistry, Wageningen
University) for help with preparative GC, and Henk Swarts (Department
of Organic Chemistry, Wageningen University) for the synthesis of
(4S)-carveol and help with the GC-MS analysis.
 |
FOOTNOTES |
*
This work was supported by Grants BIO4-CT95-0049 and
BIO4-CT96-5132 from the European Community.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ006869.
§
To whom correspondence should be addressed: Div. of Industrial
Microbiology, Department of Food Technology and Nutritional Sciences,
Wageningen University, P.O. Box 8129, 6700 EV Wageningen, The
Netherlands. Tel.: 31-317-484412; Fax: 31-317-484978; E-mail: mariet.vanderwerf@imb.ftns.wau.nl.
2
C. J. B. van der Vlugt-Bergmans, F. Barbirato,
J. A. M. de Bont, and M. J. van der Werf, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
DCPIP, dichlorophenolindophenol;
CDH, carveol dehydrogenase;
GC, gas
chromatography;
MS, mass spectrometry;
SDR, short chain
dehydrogenase/reductase.
 |
REFERENCES |
| 1.
|
Harborne, J. B.
(1991)
in
Ecological Chemistry and Biochemistry of Plant Terpenoids
(Harborne, J. B.
, and Tomas-Barberan, F. A., eds)
, pp. 399-426, Clarendon Press, Oxford
|
| 2.
|
Devon, T. K.,
and Scott, A. I.
(1972)
Handbook of Naturally Occurring Compounds: Terpenes
, Vol. II
, pp. 3-54, Academic Press, New York
|
| 3.
|
Guenther, A.,
Hewitt, C. N.,
Erickson, D.,
Fall, R.,
Geron, C.,
Graedel, T.,
Harley, P.,
Klinger, L.,
Ledau, M.,
McKay, W. A.,
Pierce, T.,
Scholes, B.,
Steinbrecher, R.,
Tallamraju, R.,
Taylor, J.,
and Zimmerman, P.
(1995)
J. Geophys. Res.
100,
8873-8892[CrossRef]
|
| 4.
|
Burdock, G. A.
(1995)
Fenaroli's Handbook of Flavour Ingredients
, 3rd Ed.
, p. 107, CRC Press, Boca Raton, FL
|
| 5.
|
Nonino, E. A.
(1997)
Perf. Flav.
22,
53-58
|
| 6.
|
Trudgill, P. W.
(1986)
in
The Bacteria: A Treatise on Structure and Function
(Sokatch, J. R., ed), Vol. X
, pp. 483-525, Academic Press, Orlando, FL
|
| 7.
|
Dhavalikar, R. S.,
Rangachari, P. N.,
and Bhattacharyya, P. K.
(1966)
Indian J. Biochem.
3,
158-164[Medline]
[Order article via Infotrieve]
|
| 8.
|
Teunissen, M. J.,
and de Bont, J. A. M.
(1995)
in
Bioflavour 95
(Étiévant, P.
, and Schreier, P., eds)
, pp. 329-337, INRA, Paris
|
| 9.
|
Gabrielyan, K. A.,
Menyailova, I. I.,
and Nakhapetyan, L. A.
(1992)
Appl. Biochem. Microbiol.
28,
241-245
|
| 10.
|
van Dyk, M. S.,
van Rensburg, E.,
and Moleleki, N.
(1998)
Biotechnol. Lett.
20,
431-436[CrossRef]
|
| 11.
|
Ballal, N. R.,
Bhattacharyya, P. K.,
and Rangachari, P. N.
(1967)
Biochem. Biophys. Res. Commun.
29,
275-280[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Ballal, N. R.,
Bhattacharyya, P. K.,
and Rangachari, P. N.
(1968)
Indian J. Biochem.
5,
1-6[Medline]
[Order article via Infotrieve]
|
| 13.
|
Cadwallader, K. R.,
Braddock, R. J.,
and Parish, M. E.
(1992)
J. Food Sci.
57,
241-244
|
| 14.
|
van der Werf, M. J.,
Swarts, H. J.,
and de Bont, J. A. M.
(1999)
Appl. Environ. Microbiol.
65,
2092-2102[Abstract/Free Full Text]
|
| 15.
|
van der Werf, M. J.,
Overkamp, K. M.,
and de Bont, J. A. M.
(1998)
J. Bacteriol.
180,
5052-5057[Abstract/Free Full Text]
|
| 16.
|
Hartmans, S.,
Smits, J. P.,
van der Werf, M. J.,
Volkering, F.,
and de Bont, J. A. M.
(1989)
Appl. Environ. Microbiol.
55,
2850-2855[Abstract/Free Full Text]
|
| 17.
|
Armstrong, J. McD.
(1964)
Biochim. Biophys. Acta
86,
194-197[Medline]
[Order article via Infotrieve]
|
| 18.
|
van der Werf, M. J.,
van den Tweel, W. J. J.,
and Hartmans, S.
(1993)
Appl. Environ. Microbiol.
59,
2823-2829[Abstract/Free Full Text]
|
| 19.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Arfman, N.,
Hektor, H. J.,
Bystrykh, L. V.,
Govorukhin, N. I.,
Dijkhuizen, L.,
and Frank, J.
(1997)
Eur. J. Biochem.
244,
426-433[Medline]
[Order article via Infotrieve]
|
| 21.
|
Barbirato, F.,
Verdoes, J. C.,
de Bont, J. A. M.,
and van der Werf, M. J.
(1998)
FEBS Lett.
438,
293-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Altschul, S. F.,
Madden, T. L.,
Schäffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402[Abstract/Free Full Text]
|
| 24.
|
Lu, G.
(1996)
Protein Data Bank Quarterly Newsletter
78,
10-11
|
| 25.
|
Schuler, G. D.,
Altschul, S. F.,
and Lipman, D. J.
(1991)
Proteins Struct. Funct. Genet.
9,
180-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Sali, A.,
and Blundell, T. L.
(1993)
J. Mol. Biol.
234,
779-815[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Brooks, B. R.,
Bruccoleri, R. E.,
Olafson, B. D.,
States, D. J.,
Swiminathan, S.,
and Karplus, M.
(1983)
J. Comp. Chem.
4,
187-217
|
| 28.
|
Laskowski, R. A.,
MacArthur, M. W.,
Moss, D. S.,
and Thornton, J. M.
(1993)
J. Appl. Crystallogr.
26,
283-291[CrossRef]
|
| 29.
|
Lüthy, R.,
Bowie, J. U.,
and Eisenberg, D.
(1992)
Nature
356,
83-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Sippl, M. J.
(1993)
Proteins
17,
355-362[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Brünger, A. T.
(1992)
X-PLOR, version 3.1
, Yale University Press, New Haven, CT
|
| 32.
|
Jones, T. A.,
Zou, J.-Y.,
Cowan, S.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sec. A
47,
110-119
|
| 33.
|
Andersson, A.,
Jordan, D.,
Schneider, G.,
and Lindqvist, Y.
(1996)
Structure
4,
1161-1170[Medline]
[Order article via Infotrieve]
|
| 34.
|
Tanaka, N.,
Nonaka, T.,
Tanabe, T.,
Yoshimoto, T.,
Tsuru, D.,
and Mitsui, Y.
(1996)
Biochemistry
35,
7715-7730[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Ghosh, D.,
Wawrzak, Z.,
Weeks, C. M.,
Duax, W. L.,
and Erman, M.
(1994)
Structure
2,
629-640[Medline]
[Order article via Infotrieve]
|
| 36.
|
Hülsmeyer, M.,
Hecht, H.-J.,
Niefind, K.,
Hofer, B.,
Eltis, L. D.,
Timmis, K. N.,
and Schomburg, D.
(1998)
Protein Sci.
7,
1286-1293[Abstract]
|
| 37.
|
Rafferty, J. B.,
Simon, J. W.,
Baldock, C.,
Artymiuk, P. J.,
Baker, P. J.,
Stuitje, A. R.,
Slabas, A. R.,
and Rice, D. W.
(1995)
Structure
3,
927-938[Medline]
[Order article via Infotrieve]
|
| 38.
|
Breton, R.,
Housset, D.,
Mazza, C.,
and Fontecilla-Camps, J. C.
(1996)
Structure
4,
905-915[Medline]
[Order article via Infotrieve]
|
| 39.
|
Varughese, K. I.,
Skinner, M. M.,
Whiteley, J. M.,
Matthews, B. W.,
and Xuong, N. H.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6080-6084[Abstract/Free Full Text]
|
| 40.
|
Tanaka, N.,
Nonaka, T.,
Nakanishi, M.,
Deyashiki, Y.,
Hara, A.,
and Mitsui, Y.
(1996)
Structure
4,
33-45[Medline]
[Order article via Infotrieve]
|
| 41.
|
Auerbach, G.,
Herrmann, A.,
Gütlich, M.,
Fischer, M.,
Jacob, U.,
Bacher, A.,
and Huber, R.
(1997)
EMBO J.
16,
7219-7230[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Rossmann, M. G.,
Moras, D.,
and Olsen, K. W.
(1974)
Nature
250,
194-199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Wierenga, R. K.,
Terpstra, P.,
and Hol, W. G. J.
(1986)
J. Mol. Biol.
187,
101-107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Jörnvall, H.,
Persson, B.,
Krook, M.,
Atrian, S.,
Gonzalez-Durarte, R.,
Feffery, J.,
and Ghosh, D.
(1995)
Biochemistry
34,
6003-6013[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
|
| 46.
|
Banthorpe, D. V.
(1995)
in
Natural Products: Their Chemistry and Biological Significance
(Mann, J., ed)
, pp. 289-359, Longman Scientific & Technical, Essex, UK
|
| 47.
|
Trudgill, P. W.
(1994)
in
Biochemistry of Microbial Degradation
(Ratledge, C., ed)
, pp. 33-61, Kluwer Academic Publishers, Dordrecht, The Netherlands
|
| 48.
|